Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.
paper
Cited
Public
Unavailable
- Authors
- Oscarson, M; McLellan, R A; Gullstén, H; Agúndez, J A; Benítez, J; Rautio, A; Raunio, H; Pelkonen, O; Ingelman-Sundberg, M
- Year
- 1999
- Journal
- FEBS letters
- PMID
- 10544257
- DOI
- 10.1016/s0014-5793(99)01364-2
The polymorphic human cytochrome P450 2A6 (CYP2A6) metabolises a number of drugs, activates a variety of precarcinogens and constitutes the major nicotine C-oxidase. A relationship between CYP2A6 genotype and smoking habits, as well as incidence of lung cancer, has been proposed. Two defective alleles have hitherto been identified, one of which is very common in Asian populations. Among Caucasians, an additional defective and frequently distributed allele (CYP2A6*3) has been suggested to play a protective role against nicotine addiction and cigarette consumption. Here, we have re-evaluated the genotyping method used for the CYP2A6*3 allele and found that a gene conversion in the 3' flanking region of 30-40% of CYP2A6*1 alleles results in genotype misclassification. In fact, no true CYP2A6*3 alleles were found among 100 Spaniards and 96 Chinese subjects. In one Spanish poor metaboliser of the CYP2A6 probe drug coumarin, we found two novel defective alleles. One, CYP2A6*5, encoded an unstable enzyme having a G479L substitution and the other was found to carry a novel type of CYP2A6 gene deletion (CYP2A6*4D). The results imply the presence of numerous defective as well as active CYP2A6 alleles as a consequence of CYP2A6/CYP2A7 gene conversion events. We conclude that molecular epidemiological studies concerning CYP2A6 require validated genotyping methods for accurate detection of all known defective CYP2A6 alleles.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genetic vulnerability and susceptibility to substance dependence. | 2011 | 21338875 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Impact of POR and cytochrome b5 variability on the genotype-phenotype discordance of CYP2A6 and CYP2D6: A quantitative analysis in Chinese human livers. | Fang Y et al. | — | 2026 | → |
| Novel CYP2A7/CYP2A6 germline hybrids associated with mutation burden in lung cancer revealed by whole-genome long-read sequencing. | Ohnami S et al. | — | 2025 | → |
| Using Real-World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants. | McCann S et al. | — | 2024 | → |
| Cigarette Smoking and Intracranial Aneurysms: A Pilot Analysis of SNPs in the CYP2A6 Gene in the Italian Population. | Ferrari E et al. | — | 2023 | → |
| Pleiotropic Functions of Cytochrome P450 Monooxygenase-Derived Eicosanoids in Cancer. | Luo Y et al. | — | 2020 | → |
| Cancer Hazard Identification Integrating Human Variability: The Case of Coumarin. | Hsieh CJ et al. | — | 2019 | → |
| Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population. | Ezzeldin N et al. | — | 2018 | → |
| Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis | Elfaki I et al. | — | 2018 | → |
| Genetic Polymorphism of <i>CYP2A6</i> and Its Relationship with Nicotine Metabolism in Male Bataknese Smokers Suffered from Lung Cancer in Indonesia. | Soeroso NN et al. | — | 2018 | → |
| CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients. | Yang L et al. | — | 2017 | → |
| Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction. | López-Flores LA et al. | — | 2017 | → |
| Functional Characterization of 34 CYP2A6 Allelic Variants by Assessment of Nicotine C-Oxidation and Coumarin 7-Hydroxylation Activities. | Hosono H et al. | — | 2017 | → |
| Variation in CYP2A6 Activity and Personalized Medicine. | Tanner JA et al. | — | 2017 | → |
| Combinations of CYP2A6*4 and Glutathione S-Transferases Gene Polymorphisms Modify the Association Between Maternal Secondhand Smoke Exposure During Pregnancy and Small-for-Gestational-Age. | Xie C et al. | — | 2015 | → |
| CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers. | Hosono H et al. | — | 2015 | → |
| Genotyping of wild-type cytochrome P450 2A6 and whole-gene deletion using human blood samples and a multiplex real-time polymerase chain reaction method with dual-labeled probes. | Shimizu M et al. | — | 2015 | → |
| Is there evidence for potential harm of electronic cigarette use in pregnancy? | Suter MA et al. | — | 2015 | → |
| The allele frequency of CYP2A6*4 in four ethnic groups of China. | Pang C et al. | — | 2015 | → |
| High CYP2A6 enzyme activity as measured by a caffeine test and unique distribution of CYP2A6 variant alleles in Ethiopian population. | Aklillu E et al. | — | 2014 | → |
| Advances in molecular modeling of human cytochrome P450 polymorphism. | Martiny VY et al. | — | 2013 | → |
| Association of CYP2A6*4 with susceptibility of lung cancer: a meta-analysis. | Wang L | — | 2013 | → |
| Comparisons of CYP2A6 genotype and enzyme activity between Swedes and Koreans. | Djordjevic N et al. | — | 2013 | → |
| CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis. | Liu YL et al. | — | 2013 | → |
| Cytochrome p450 metabolism of betel quid-derived compounds: implications for the development of prevention strategies for oral and pharyngeal cancers. | Lin CY et al. | — | 2013 | → |
| Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants. | Uno T et al. | — | 2013 | → |
| Cytochrome P450 variations in different ethnic populations. | McGraw J et al. | — | 2012 | → |
| Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35). | Han S et al. | — | 2012 | → |
| Gene, ethnic and gender influences predisposition of adverse drug reactions to artesunate among Malaysians. | Yusof W et al. | — | 2012 | → |
| Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population. | Krishnakumar D et al. | — | 2012 | → |
| PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6. | McDonagh EM et al. | — | 2012 | → |
| Relationship between amounts of daily cigarette consumption and abdominal obesity moderated by CYP2A6 genotypes in Chinese male current smokers. | Liu T et al. | — | 2012 | → |
| Associations of CYP2A6 genotype with smoking behaviors in southern China. | Liu T et al. | — | 2011 | → |
| Differences between Spaniards and Ecuadorians in CYP2A6 allele frequencies: comparison with other populations. | Soriano A et al. | — | 2011 | → |
| Genetic vulnerability and susceptibility to substance dependence. | Bierut LJ | — | 2011 | → |
| Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes. | Lee IS et al. | — | 2011 | → |
| In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population. | Djordjevic N et al. | — | 2010 | → |
| Pharmacogenomics of maternal tobacco use: metabolic gene polymorphisms and risk of adverse pregnancy outcomes. | Aagaard-Tillery K et al. | — | 2010 | → |
| A bioinformatics approach for the phenotype prediction of nonsynonymous single nucleotide polymorphisms in human cytochromes P450. | Wang LL et al. | — | 2009 | → |
| Environmental influences on epigenetic profiles. | Suter MA et al. | — | 2009 | → |
| Gene-gene interactions of CYP2A6 and MAOA polymorphisms on smoking behavior in Chinese male population. | Tang X et al. | — | 2009 | → |
| High prevalence of CYP2A6*4 and CYP2A6*9 alleles detected among a Malaysian population. | Yusof W et al. | — | 2009 | → |
| In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function. | di Iulio J et al. | — | 2009 | → |
| Molecular genetics of nicotine metabolism. | Mwenifumbo JC et al. | — | 2009 | → |
| Polymorphism of human cytochrome P450 enzymes and its clinical impact. | Zhou SF et al. | — | 2009 | → |
| Analysis of copy number variation in the rhesus macaque genome identifies candidate loci for evolutionary and human disease studies. | Lee AS et al. | — | 2008 | → |
| CYP2A6 polymorphisms and risk for tobacco-related cancers. | Rossini A et al. | — | 2008 | → |
| Genetic polymorphisms of CYP2A6 affect the in-vivo pharmacokinetics of pilocarpine. | Endo T et al. | — | 2008 | → |
| Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism. | Mwenifumbo JC et al. | — | 2008 | → |
| A novel duplication type of CYP2A6 gene in African-American population. | Fukami T et al. | — | 2007 | → |
| Characterization of orphan human cytochromes P450. | Stark K et al. | — | 2007 | → |
| Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. | Mwenifumbo JC et al. | — | 2007 | → |
| Past and future applications of CYP450-genetic polymorphisms for biomonitoring of environmental toxicants. | Yi B et al. | — | 2007 | → |
| Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. | Gresner P et al. | — | 2007 | → |
| Racially classified social group tobacco-related health disparities: what is the role of genetics? | Fernander AF | — | 2007 | → |
| Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants. | Sansen S et al. | — | 2007 | → |
| 3'-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression. | Wang J et al. | — | 2006 | → |
| Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics. | Al Koudsi N et al. | — | 2006 | → |
| CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro. | Rossini A et al. | — | 2006 | → |
| CYP2A6 polymorphisms in Malays, Chinese and Indians. | Nurfadhlina M et al. | — | 2006 | → |
| CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele. | Fukami T et al. | — | 2006 | → |
| The genetics of nicotine dependence: relationship to pancreatic cancer. | MacLeod SL et al. | — | 2006 | → |
| Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort. | Gambier N et al. | — | 2005 | → |
| Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity. | Fukami T et al. | — | 2005 | → |
| CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents. | Huang S et al. | — | 2005 | → |
| Cytochrome P450 gene-based drug prescribing and factors impacting translation into routine clinical practice. | Wilke RA et al. | — | 2005 | → |
| High prevalence of cytochrome P450 2A6*1A alleles in a black African population of Ghana. | Gyamfi MA et al. | — | 2005 | → |
| Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. | Malaiyandi V et al. | — | 2005 | → |
| Integrative epidemiology: from risk assessment to outcome prediction. | Spitz MR et al. | — | 2005 | → |
| Inter-gene correlation on oligonucleotide arrays: how much does normalization matter? | Gold DL et al. | — | 2005 | → |
| Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation. | Nakajima M et al. | — | 2005 | → |
| Metabolism and disposition kinetics of nicotine. | Hukkanen J et al. | — | 2005 | → |
| Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs. | Yamada K et al. | — | 2005 | → |
| Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy. | Mango R et al. | — | 2005 | → |
| Three haplotypes associated with CYP2A6 phenotypes in Caucasians. | Haberl M et al. | — | 2005 | → |
| A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity. | Pitarque M et al. | — | 2004 | → |
| Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. | Nelson DR et al. | — | 2004 | → |
| Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms. | Kim K et al. | — | 2004 | → |
| Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. | Schoedel KA et al. | — | 2004 | → |
| Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility. | Cauffiez C et al. | — | 2004 | → |
| Genetics of tobacco use. | Maserejian NN et al. | — | 2004 | → |
| Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. | Solus JF et al. | — | 2004 | → |
| Identification of deletion-junction site of CYP2A6*4B allele lacking entire coding region of CYP2A6 in Japanese. | Ariyoshi N et al. | — | 2004 | → |
| Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted. | Yamanaka H et al. | — | 2004 | → |
| Novel human CYP2A6 alleles confound gene deletion analysis. | Nakajima M et al. | — | 2004 | → |
| Polymorphic NF-Y dependent regulation of human nicotine C-oxidase (CYP2A6). | von Richter O et al. | — | 2004 | → |
| Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults. | Ando M et al. | — | 2003 | → |
| Candidate gene case-control studies. | Daly AK | — | 2003 | → |
| Comparative American and Japanese tobacco smoke uptake parameters after overnight tobacco deprivation. | Domino EF et al. | — | 2003 | → |
| Genetic influences on smoking behavior and nicotine dependence: a review. | Yoshimasu K et al. | — | 2003 | → |
| Genetic polymorphisms of estrogen receptor-alpha: possible implications for targeted osteoporosis therapy. | Ongphiphadhanakul B | — | 2003 | → |
| Heterogeneity of toxicant response: sources of human variability. | Aldridge JE et al. | — | 2003 | → |
| Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. | Tricker AR | — | 2003 | → |
| Pharmacogenetics of the major polymorphic metabolizing enzymes. | Daly AK | — | 2003 | → |
| PM frequencies of major CYPs in Asians and Caucasians. | Mizutani T | — | 2003 | → |
| Polymorphic CYP2A6 and its clinical and toxicological significance. | Rautio A | — | 2003 | → |
| Advancing the medical management of epilepsy: disease modification and pharmacogenetics. | Glauser TA | — | 2002 | → |
| An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles. | Xu C et al. | — | 2002 | → |
| A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur. | Daigo S et al. | — | 2002 | → |
| Characterization of a genotype previously designated as CYP2A6 D-type: CYP2A6*4B, another entire gene deletion allele of the CYP2A6 gene in Japanese. | Ariyoshi N et al. | — | 2002 | → |
| Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity. | Oscarson M et al. | — | 2002 | → |
| CYP2A6 genetic variation and potential consequences. | Xu C et al. | — | 2002 | → |
| Effects of whole deletion of CYP2A6 on nicotine metabolism in humans. | Zhang X et al. | — | 2002 | → |
| Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer. | Kiyohara C et al. | — | 2002 | → |
| Genetic polymorphism of human cytochrome p450 involved in drug metabolism. | Nagata K et al. | — | 2002 | → |
| Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism. | Yoshida R et al. | — | 2002 | → |
| Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. | Zhang X et al. | — | 2002 | → |
| Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. | Tyndale RF et al. | — | 2002 | → |
| Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6. | Nakajima M et al. | — | 2002 | → |
| A novel single nucleotide polymorphism altering stability and activity of CYP2a6. | Ariyoshi N et al. | — | 2001 | → |
| Candidate gene case-control association studies: advantages and potential pitfalls. | Daly AK et al. | — | 2001 | → |
| Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method. | Paschke T et al. | — | 2001 | → |
| CYP2A6*6, a novel polymorphism in cytochrome p450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity. | Kitagawa K et al. | — | 2001 | → |
| Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity. | Rodríguez-Antona C et al. | — | 2001 | → |
| Determination of coumarin metabolism in Turkish population. | Cok I et al. | — | 2001 | → |
| Genetic clues to the molecular basis of tobacco addiction and progress towards personalized therapy. | Walton R et al. | — | 2001 | → |
| Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes. | Ingelman-Sundberg M | — | 2001 | → |
| Genetic variability in susceptibility and response to toxicants. | Ingelman-Sundberg M | — | 2001 | → |
| New directions in the genetic mechanisms underlying nicotine addiction. | Munafò M et al. | — | 2001 | → |
| Nicotine metabolism and CYP2A6 allele frequencies in Koreans. | Kwon JT et al. | — | 2001 | → |
| Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19. | Hoffman SM et al. | — | 2001 | → |
| Polymorphisms of CYP2A6 and its practical consequences. | Raunio H et al. | — | 2001 | → |
| Resequencing the sulfotransferase SULT1 gene provides new insights, while illuminating challenges that lie ahead for pharmacogenomics. | Evans WE et al. | — | 2001 | → |
| Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines: expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S. typhimurium YG7108. | Kushida H et al. | — | 2000 | → |
| Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. | Rao Y et al. | — | 2000 | → |
| Gender differences in addiction and recovery. | Haseltine FP | — | 2000 | → |
| Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment. | Brockmöller J et al. | — | 2000 | → |
| Polymorphisms in genes involved in neurotransmission in relation to smoking. | Arinami T et al. | — | 2000 | → |
| Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C. | Ariyoshi N et al. | — | 2000 | → |